Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 12, 2026 2.936
November 11, 2026 2.961
November 10, 2026 2.828
November 09, 2026 2.840
November 06, 2026 2.792
November 05, 2026 2.787
November 04, 2026 2.873
November 03, 2026 3.004
November 02, 2026 2.967
October 30, 2026 2.864
October 29, 2026 2.527
October 28, 2026 2.510
October 27, 2026 2.519
October 26, 2026 2.493
October 23, 2026 2.485
October 22, 2026 2.528
October 21, 2026 2.487
October 20, 2026 2.492
October 19, 2026 2.414
October 16, 2026 2.441
October 15, 2026 2.458
October 14, 2026 2.403
October 13, 2026 2.325
October 12, 2026 2.355
October 09, 2026 2.304
Date Value
October 08, 2026 2.283
October 07, 2026 2.291
October 06, 2026 2.280
October 05, 2026 2.242
October 02, 2026 2.269
October 01, 2026 2.268
September 30, 2026 2.341
September 29, 2026 2.447
September 28, 2026 2.453
September 25, 2026 2.570
September 24, 2026 2.596
September 23, 2026 2.614
September 22, 2026 2.621
September 21, 2026 2.603
September 18, 2026 2.559
September 17, 2026 2.574
September 16, 2026 2.526
September 15, 2026 2.524
September 14, 2026 2.588
September 11, 2026 2.548
September 10, 2026 2.586
September 09, 2026 2.634
September 08, 2026 2.642
September 04, 2026 2.699
September 03, 2026 2.750

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Gilead Sciences, Inc. 15.99
AbbVie, Inc. --
Vertex Pharmaceuticals, Inc. 6.580
Amgen, Inc. 17.60
Biogen, Inc. 1.956

Price to Book Value Related Metrics